1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Urinary Bladder Cancer: new trials by email Literature Review of Urinary Bladder Cancer trials Research Report on Urinary Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer GemCis + Panitumumab, GemCis - Urinary Bladder Cancer | Phase 2 | Terminated | WiSP Wissenschaftlicher Service Pharma GmbH | 2 | 2010-07-01 | 2015-06-03 |
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Panitumumab (1)
WiSP Wissenschaftlicher Service Pharma GmbH (1)
Germany (1)
2009 (1)